Current StartLab residents:
AC Bioscience is a clinical-stage biotech company developing personalised molecular therapies for solid tumour cancer patients, with a clinical focus on colorectal cancer and metastatic pancreatic cancer.
Adaptyv Biosystems is building a next-generation protein engineering platform by coupling computational prediction, experimental validation with cell-free synthetic biology and high-throughput nanofluidics.
AKYmed works in the field of reproductive technology, developing next-generation male fertility analysis solutions for doctors, laboratories, clinics, hospitals, breeding studs and research institutes.
Alithea Genomics is a biotech developing high-throughput transcriptomics solutions for research and biomarker discovery, using large-scale RNA sequencing.
arcoris bio enables next-generation multiplex spatial biomarker detection for research and diagnostics through its multiomics signal enhancement nanotechnology, MUSE.
Atinary is a deep tech start-up that uses AI, machine learning, robotics and cloud computing to accelerate R&D and optimise processes for breakthrough in several industries, including pharma, biotech and materials.
Genknowme works on developing an innovative blood test that identifies key epigenetic markers, to help adults track, maintain and improve their well-being and potential longevity.
Limula is working to develop technology that can perform every step of the cell therapy manufacturing process in a single device, directly at the point of care.
MediCrops is a pharmaceutical company specialising in the production and processing of medicinal cannabis preparations containing tetrahydrocannabinol (THC).
Mosaic NeuroSciences develops new therapeutic solutions in the fields of neurology and neurodegenerative disorders, such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).
ND Biosciences develops next-generation diagnostics and therapeutics to prevent or reverse the pathological protein aggregation observed in neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease.
Otten Life Sciences Consulting
Otten Life Sciences Consulting offers tailored services in the finance and healthcare industries for investors, shareholders and life sciences companies.
Parithera leverages liquid biopsy to provide a minimally invasive diagnostic that analyses cancer treatment resistance and allows clinicians to adjust treatment regimen.
PDC Therapeutics is a clinical-stage biotech company developing smart nanomedicines for targeted therapies, using polymer-drug conjugate technology, that seek to provide cancer patients with an optimal therapeutic index.
Sulfiscon is a start -p developing small molecule allosteric modulators that regulate cellular hydrogen sulfide (H2S) production in order to alleviate disorders of pathologic calcification and inflammation.
Testmate Health is a medtech start-up developing a rapid at-home self-testing kit: a simple urine test for four common sexually transmitted diseases that provides results in minutes.
Vanarix is a clinical-stage start-up specialising in regenerative medicine, which aims to develop innovative and effective cell-based therapies, such as Cartibeads for treating articular cartilage damage.
VitalizeDx focuses on measurements and analyses of saliva for diagnostic purposes to the end of developing therapeutic strategies in the fields of wellness, preventive medicine and chronic disease.
This list is not complete. It only includes companies that wish for their Biopôle location to be made public.